Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
This Quarter Return
+7.84%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$15.3B
AUM Growth
+$15.3B
(+18%)
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
11.1%
Top 10 Holdings %
Top 10 Hldgs %
21.23%
Holding
1,045
New
20
Increased
895
Reduced
82
Closed
14
Top Buys
| 1 |
Apple
AAPL
|
$77.9M |
| 2 |
Microsoft
MSFT
|
$63.4M |
| 3 |
Amazon
AMZN
|
$62.9M |
| 4 |
Vuzix
VUZI
|
$48.8M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$36.6M |
Top Sells
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$23.7M |
| 2 |
DFS
Discover Financial Services
DFS
|
$21.3M |
| 3 |
Home Depot
HD
|
$19M |
| 4 |
Honeywell
HON
|
$9.91M |
| 5 |
Carrier Global
CARR
|
$7.49M |
Sector Composition
| 1 | Technology | 23.93% |
| 2 | Consumer Discretionary | 12.7% |
| 3 | Healthcare | 12.17% |
| 4 | Financials | 11.66% |
| 5 | Communication Services | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYBE
951
DELISTED
Cyberoptics Corp
CYBE
| $306K | ﹤0.01% |
11,786
+4,466
| +61% | +$116K |
|
|
AIV
952
Aimco
AIV
$1.11B
| $304K | ﹤0.01% |
49,447
| – | – |
|
953
Wipro
WIT
$28.9B
| $301K | ﹤0.01% |
47,400
+10,167
| +27% | +$64.6K |
|
954
Inovio Pharmaceuticals
INO
$126M
| $298K | ﹤0.01% |
32,073
+10,154
| +46% | +$94.3K |
|
955
Magnachip Semiconductor
MX
$113M
| $298K | ﹤0.01% |
11,986
+3,027
| +34% | +$75.3K |
|
|
CSR
956
Centerspace
CSR
$997M
| $297K | ﹤0.01% |
4,372
+284
| +7% | +$19.3K |
|
957
Adverum Biotechnologies
ADVM
$64.6M
| $285K | ﹤0.01% |
28,892
+9,111
| +46% | +$89.9K |
|
958
News Corp Class B
NWS
$19.1B
| $285K | ﹤0.01% |
12,146
| – | – |
|
|
TCRR
959
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $280K | ﹤0.01% |
12,699
+4,011
| +46% | +$88.4K |
|
960
ING
ING
$70.3B
| $277K | ﹤0.01% |
22,632
+6,647
| +42% | +$81.4K |
|
961
Sanofi
SNY
$121B
| $273K | ﹤0.01% |
5,512
+2,104
| +62% | +$104K |
|
|
AHH
962
Armada Hoffler Properties
AHH
$584M
| $272K | ﹤0.01% |
21,656
+2,715
| +14% | +$34.1K |
|
963
uniQure
QURE
$896M
| $272K | ﹤0.01% |
8,085
+2,423
| +43% | +$81.5K |
|
964
Novartis
NVS
$245B
| $264K | ﹤0.01% |
3,093
+1,086
| +54% | +$92.7K |
|
965
Grifois
GRFS
$6.78B
| $261K | ﹤0.01% |
15,106
+5,619
| +59% | +$97.1K |
|
966
RLX Technology
RLX
$3.09B
| $261K | ﹤0.01% |
+25,215
| New | +$261K |
|
|
TECX
967
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $260K | ﹤0.01% |
20,494
+7,205
| +54% | +$91.4K |
|
|
GOOD
968
Gladstone Commercial Corp
GOOD
$626M
| $255K | ﹤0.01% |
13,056
+1,760
| +16% | +$34.4K |
|
969
Royal Bank of Canada
RY
$205B
| $254K | ﹤0.01% |
2,753
+819
| +42% | +$75.6K |
|
|
UMH
970
UMH Properties
UMH
$1.33B
| $251K | ﹤0.01% |
13,089
| – | – |
|
971
Sea Limited
SE
$110B
| $249K | ﹤0.01% |
1,117
+326
| +41% | +$72.7K |
|
|
BLUE
972
DELISTED
bluebird bio
BLUE
| $246K | ﹤0.01% |
8,144
+2,696
| +49% | +$81.4K |
|
|
EVOP
973
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $242K | ﹤0.01% |
8,805
+2,585
| +42% | +$71K |
|
974
Atara Biotherapeutics
ATRA
$84.6M
| $238K | ﹤0.01% |
16,575
+4,967
| +43% | +$71.3K |
|
|
JMIA
975
Jumia Technologies
JMIA
$1.05B
| $238K | ﹤0.01% |
6,720
+1,552
| +30% | +$55K |
|